Is Tilray Stock a Buy Post Fiscal Q2 Results?
Canadian cannabis giant Tilray (NASDAQ:TLRY) announced its fiscal second quarter of 2022 results last week. The company reported net revenue of $155 […]
Canadian cannabis giant Tilray (NASDAQ:TLRY) announced its fiscal second quarter of 2022 results last week. The company reported net revenue of $155 […]
Growing awareness and public support for medical cannabis around the world has pushed regulatory authorities to consider the legalization of medical cannabis, […]
Aphria and Tilray will host special shareholder meetings next month on the proposed merger between the cannabis producers, the companies said. The […]
Canada’s government is extending a pandemic-related wage-subsidy program that has been tapped by more than a dozen federally regulated cannabis producers. The […]
A large Canadian pension manager unloaded some marijuana investments over the past couple of years while raising its holdings in licensed producers […]
On-again, off-again merger talks between rival cannabis producers Tilray and Aphria had their genesis in October 2019 when an unidentified investment bank […]
Cannabis producer Tilray cut its annual loss to $271 million for 2020, an improvement from the Nanaimo, British Columbia company’s $321 million […]
After a slow start following a disappointing 2019, M&A in the cannabis space closed 2020 with a bang, with more than $600 […]
Canadian cannabis company Aphria on Thursday reported increased quarterly revenue for the quarter ended Nov. 30, with a net loss of 120.6 […]
A number of executives in the cannabis industry are among the highest-compensated CEOs in Canada, according to a new analysis of 2019 […]